Title Created Date
Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study 22 September 2017
Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors 22 September 2017
1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling 21 September 2017
Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes 21 September 2017
Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro 20 September 2017
Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors 15 September 2017
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer 15 September 2017
Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice 15 September 2017
New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase 13 September 2017
Melatonin: does it have utility in the treatment of hematologic neoplasms? 08 September 2017
Display #